1.Differential Response of Surfactant Protein-A Genetic Variants to Dexamethasone Treatment.
Eul Soon KIM ; In Kyu LEE ; Myung Ho OH ; Chong Woo BAE
Journal of the Korean Pediatric Society 2003;46(4):335-339
PURPOSE: Surfactant protein A(SP-A) is involved in surfactant physiology and structure, and plays a major role in innate host defense and inflammatory processes in the lung. Steroid therapy is widely used for mothers who threaten to deliver prematurely and also used commonly in the management of preterm infants with chronic lung disease. Two SP-A genes(SP-A1, SP-A2) and several alleles have been characterized for each SP-A gene in human. Preliminary evidence indicates that differences may exist among alleles in response to Dexamethasone(Dexa) and that the SP-A 3'UTR plays a role in this process. We studied whether 3'UTR-mediated differences exist among the most frequently found SP-A alleles in response to Dexa. METHODS: Constructs containing the 3'UTR from eight different SP-A alleles were made using luciferase as a the reporter gene. These constructs were driven by the SV40 promotor and were transfected along with a transfection control vector in H441 cells that express SP-A. The activity of the reporter gene in the presence or absence of Dexa(100 nM) treatment was measured. All the experiments for the eight SP-A alleles studied, were performed in triplicate and repeated five times. The results were normalized to the transfection control. RESULTS: Expression of alleles of 6A3, 6A, 1A were significantly decreased in response to Dexa. CONCLUSION: Three UTR mediated differences exist among human SP-A variants both in the basal expression and in response to Dexa. These genotype-dependent differences may point to a need for a careful consideration of individual use of steroid treatment in the prematurely born infant.
3' Untranslated Regions
;
Alleles
;
Dexamethasone*
;
Genes, Reporter
;
Humans
;
Infant
;
Infant, Newborn
;
Infant, Premature
;
Luciferases
;
Lung
;
Lung Diseases
;
Mothers
;
Physiology
;
Transfection
2.MiR373 and miR542-5p regulate the replication of enterovirus 71 in rhabdomyosarcoma cells.
Chinese Journal of Biotechnology 2014;30(6):943-953
MicroRNAs (miRNAs) play an important role in infection and replication of virus in host cells. To identify cellular miRNAs involved in the host response to enterovirus 71 (EV71) infection, we examined miRNAs effects on the replication of EV71 in rhabdomyosarcoma cells. We constructed target gene of miRNAs screening system. 3'untranslated region (UTR) dual luciferase reporter analysis was used to identify putative miRNA targets in the EV71 virus genome. First, 13 segments of EV71 virus genomes were inserted to the pMIR vector and the luciferase expression were assayed to identify the target gene of putative miRNA. The reporter gene expression of the cells transfected with the vector containing 5'-UTR was significantly downregulated. Then we screened the miRNAs that may target to 5'-UTR using online analysis programs. Furthermore, Western blotting and real-time PCR test were performed to investigate the effect of miRNAs on viral replication. The study showed that miR373 and miR542-5p could suppress the replication of EV71 virus through binding to the 5'-UTR gene. Cellular miRNAs could regulate the replication of EV71 virus in host cells, and our paper should report the role of miR373 and miR542-5p in this regulation for the first time. Our findings supported the notion that the cellular miRNAs might be essential in the host-pathogen interactions.
3' Untranslated Regions
;
5' Untranslated Regions
;
Down-Regulation
;
Enterovirus A, Human
;
physiology
;
Enterovirus Infections
;
virology
;
Gene Expression
;
Host-Pathogen Interactions
;
Humans
;
MicroRNAs
;
genetics
;
Rhabdomyosarcoma
;
virology
;
Tumor Cells, Cultured
;
Virus Replication
3.Low-dose radiation response of the p21(WAF1/CIP1) gene promoter transduced by adeno-associated virus vector.
Mitsuru NENOI ; Kazuhiro DAINO ; Sachiko ICHIMURA ; Shin Ichiro TAKAHASH ; Teruo AKUTA
Experimental & Molecular Medicine 2006;38(5):553-564
In cancer gene therapy, restriction of antitumor transgene expression in a radiation field by use of ionizing radiation-inducible promoters is one of the promising approaches for tumor-specific gene delivery. Although tumor suppressor protein p53 is induced by low doses (<1 Gy) of radiation, there have been only a few reports indicating potential utilization of a p53-target gene promoter, such as that of the p21 gene. This is mainly because the transiently transfected promoter of p53-target genes is not much sensitive to radiation. We examined the response of the p21 gene promoter to low-dose radiation when transduced into a human breast cancer cell line MCF-7 by use of recombinant adeno-associated virus (rAAV) vectors. It was shown that the p21 gene promoter transduced by rAAV vectors was more highly radiation-responsive than that transiently transfected by electroporation. A significant induction of the p21 gene promoter by radiation of low doses down to 0.2 Gy was observed. When cells were transduced with the p21 gene promoter-driven HSVtk gene by rAAV vector, they were significantly sensitized to repetitive treatment with low dose radiation (1 Gy) in the presence of the prodrug ganciclovir. It was therefore considered that the p21 gene promoter in combination with a rAAV vector is potentially usable for the development of a low-dose radiation-inducible vector for cancer gene therapy.
X-Rays
;
Tumor Cells, Cultured
;
Transgenes/*radiation effects
;
Transduction, Genetic
;
Promoter Regions (Genetics)/*radiation effects
;
Humans
;
Genetic Vectors/*radiation effects
;
Gene Therapy/methods
;
Electroporation/methods
;
Dose-Response Relationship, Radiation
;
Cyclin-Dependent Kinase Inhibitor p21/*genetics
;
Adenoviridae
;
3' Untranslated Regions/physiology
4.MicroRNA-150 inhibits osteosarcoma cell proliferation by targeting RUNX2 gene.
Longfei WANG ; Weiguo WANG ; Jinsong LI ; Shijie CHEN ; Ruisen ZHAN
Journal of Central South University(Medical Sciences) 2016;41(12):1285-1290
To investigate the microRNA (miR)-150 expression level in human osteosarcoma cell lines (Saos-2, MG-63) and its function in cell proliferation, and to explore the potential molecular mechanisms.
Methods: MiR-150 expression levels in human osteosarcoma cell lines (Saos-2, MG-63) and normal osteoblast cell line (NHOst) were detected by relative quantitative real-time PCR (qRT-PCR). MiR-150 was overexpressed in Saos-2 and MG-63 cells by lentivirus infection. Cell proliferation rates were monitored by MTS assay. RUNX2 and β-actin protein levels were examined by Western blot. Inhibitory effect of miR-150 on binding RUNX2 3'-UTR was detected by Dual-Luciferase assay.
Results: MiR-150 expression level is lower in human osteosarcoma cell lines (Saos-2, MG-63) compared to the normal osteoblast cell line (NHOst) (0.23±0.02 and 0.32±0.03 vs 1.00±0.02), which showed statistical significance (P<0.01). After lentivirus infection, miR-150 level increased in Saos-2 (P<0.01) and MG-63 cells (P<0.01). Overexpression of miR-150 decreased cell proliferation and RUNX2 protein level in Saos-2 and MG-63 cells. The binding of miR-150 to RUNX2 3'-UTR decreased luciferase activity by 69% in Saos-2 cells (P<0.05) and 59% in MG-63 cells (P<0.05). Administration of exogenous RUNX2 recovered the cell proliferation in miR-150 overexpressed Saos-2 and MG-63 cell lines (P<0.01).
Conclusion: MiR-150 inhibites proliferation in human osteosarcoma cell lines through binding to RUNX2 3'-UTR, resulting in the reducion of RUNX2 protein level.
3' Untranslated Regions
;
Actins
;
metabolism
;
Bone Neoplasms
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
genetics
;
Core Binding Factor Alpha 1 Subunit
;
drug effects
;
genetics
;
pharmacology
;
physiology
;
Gene Expression Regulation, Neoplastic
;
drug effects
;
genetics
;
Humans
;
MicroRNAs
;
pharmacology
;
Osteoblasts
;
physiology
;
Osteosarcoma
;
genetics
;
physiopathology